University of Basel research suggests blue light could break chemistry rule to create 3D drug structures

Health

Researchers at the University of Basel report blue light may break a long-standing chemistry rule, enabling the construction of 3D drug molecules. This approach could theoretically allow drugs to bind more precisely to biological targets, potentially improving treatment efficacy while reducing side effects. The work represents a new pathway for molecular design but lacks details on current testing stages or real-world applications. Since the source is unreachable, the full mechanism and practical implications remain with the researchers. This advance sits at the intersection of health innovation and knowledge production, though its direct impact on accessible medicines is unverified. The source provides only this headline-level claim; deeper technical and implementation details sit with the University of Basel team.

Source: Phys.org